Clinical Trial Update: Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigating chemoradiotherapy combined with cetuximab for nasopharyngeal carcinoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Cetuximab (Erbitux) (Cetuximab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2 | Status: COMPLETED